Showing results (121-130 of 835) with videos related to
Sort By:
Pageof 84
Statistics in Medicine|June 12, 2019
Adaptive group-sequential design with population enrichment in phase 3 randomized controlled trials with two binary co-primary endpointsArup K Sinha, Lemuel Moye, Linda B Piller, et al.JAMA|December 22, 2011
Association between chlorthalidone treatment of systolic hypertension and long-term survivalJohn B Kostis, Javier Cabrera, Jerry Q Cheng, et al.Journal of the American Heart Association|August 1, 2019
Disparities in Socioeconomic Context and Association With Blood Pressure Control and Cardiovascular Outcomes in ALLHATAndi Shahu, Jeph Herrin, Sanket S Dhruva, et al.Current Cardiology Reports|July 29, 2017
The Impact of Antihypertensive Medications on Bone Mineral Density and Fracture RiskJoshua I Barzilay, Barry R Davis, Sara L Pressel, et al.The American Journal of Cardiology|May 29, 2004
Relation of metformin treatment to clinical events in diabetic patients undergoing percutaneous interventionJohn Kao, Jonathan Tobis, Robyn L McClelland, et al.American Journal of Epidemiology|March 6, 2026
Estimating the Effect of Pravastatin versus Usual Care Under Full Adherence in the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial-Lipid Lowering Trial (ALLHAT-LLT)Rienna G Russo, Anna Siefkas, Barry R Davis, et al.World Journal of Gastroenterology|January 13, 2004
Expression of estrogen receptor beta in human colorectal cancerLi-Qun Xie, Jie-Ping Yu, He-Sheng LuoJournal of Applied Statistics|March 31, 2015
Simultaneous inference of a misclassified outcome and competing risks failure time dataSheng Luo, Xiao Su, Min Yi, et al.Journal of Alzheimer'S Disease : JAD|December 19, 2022
Novel Genetic Variants in TP37, PIK3R1, CALM1, and PLCG2 of the Neurotrophin Signaling Pathway Are Associated with the Progression from Mild Cognitive Impairment to Alzheimer's DiseaseHuiyue Li, Hongliang Liu, Michael W Lutz, et al.Statistics in Medicine|April 17, 2019
A Bayesian approach for individual-level drug benefit-risk assessmentKan Li, Sheng Luo, Sammy Yuan, et al.Pageof 84